Literature DB >> 26818651

To overcome two diseases with one pill.

Masaki Mogi1, Masatsugu Horiuchi1.   

Abstract

Mesh：

Year:  2016        PMID： 26818651     DOI： 10.1038/hr.2016.3

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  15 in total

1.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

2.  Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6.

Authors:  Masao Doi; Yukari Takahashi; Rie Komatsu; Fumiyoshi Yamazaki; Hiroyuki Yamada; Shogo Haraguchi; Noriaki Emoto; Yasushi Okuno; Gozoh Tsujimoto; Akihiro Kanematsu; Osamu Ogawa; Takeshi Todo; Kazuyoshi Tsutsui; Gijsbertus T J van der Horst; Hitoshi Okamura
Journal:  Nat Med       Date:  2009-12-13       Impact factor: 53.440

3.  Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension.

Authors:  Ilkka Tikkanen; Kirsi Narko; Cordula Zeller; Alexandra Green; Afshin Salsali; Uli C Broedl; Hans J Woerle
Journal:  Diabetes Care       Date:  2014-09-30       Impact factor: 19.112

4.  Association of circadian genes with diurnal blood pressure changes and non-dipper essential hypertension: a genetic association with young-onset hypertension.

Authors:  Hsin-Bang Leu; Chia-Min Chung; Shing-Jong Lin; Kuang-Mao Chiang; Hsin-Chou Yang; Hung-Yun Ho; Chih-Tai Ting; Tsung-Hsien Lin; Sheng-Hsiung Sheu; Wei-Chuan Tsai; Jyh-Hong Chen; Wei-Hsian Yin; Ting-Yu Chiu; Chin-Iuan Chen; Cathy Sj Fann; Yuan-Tsong Chen; Wen-Harn Pan; Jaw-Wen Chen
Journal:  Hypertens Res       Date:  2014-11-20       Impact factor: 3.872

5.  Effect of epinephrine on alpha-methyl-D-glucopyranoside uptake in renal proximal tubule cells.

Authors:  Eun Jung Kim; Yun Jung Lee; Jang Hern Lee; Ho Jae Han
Journal:  Cell Physiol Biochem       Date:  2004

6.  Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients.

Authors:  Sukyoun Shin; Hyunjong Song; Sang-Kwon Oh; Kyung Eob Choi; Ho Kim; Sunmee Jang
Journal:  Hypertens Res       Date:  2013-08-22       Impact factor: 3.872

7.  Decreased perivascular CGRP-containing nerves in Otsuka Long-Evans Tokushima Fatty rats with insulin resistance and hypertension.

Authors:  Shingo Takatori; Hiroki Fujiwara; Yoshito Zamami; Narumi Hashikawa-Hobara; Hiromu Kawasaki
Journal:  Hypertens Res       Date:  2013-11-14       Impact factor: 3.872

8.  Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.

Authors:  Bowen Lin; Nobutaka Koibuchi; Yu Hasegawa; Daisuke Sueta; Kensuke Toyama; Ken Uekawa; MingJie Ma; Takashi Nakagawa; Hiroaki Kusaka; Shokei Kim-Mitsuyama
Journal:  Cardiovasc Diabetol       Date:  2014-10-26       Impact factor: 9.951

9.  Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats.

Authors:  Kazi Rafiq; Yoshihide Fujisawa; Shamshad J Sherajee; Asadur Rahman; Abu Sufiun; Hiroyuki Kobori; Hermann Koepsell; Masaki Mogi; Masatsugu Horiuchi; Akira Nishiyama
Journal:  Diabetologia       Date:  2015-10-08       Impact factor: 10.122

10.  The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.

Authors:  David Zi Cherney; Bruce A Perkins; Nima Soleymanlou; Ronnie Har; Nora Fagan; Odd Erik Johansen; Hans-Juergen Woerle; Maximilian von Eynatten; Uli C Broedl
Journal:  Cardiovasc Diabetol       Date:  2014-01-29       Impact factor: 9.951
View more
  1 in total

Review 1.  Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure.

Authors:  Asadur Rahman; Hirofumi Hitomi; Akira Nishiyama
Journal:  Hypertens Res       Date:  2017-01-19       Impact factor: 3.872
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.